The decreased
tumor size and enhanced
tumor rejection in DGKζ - deficient mice indirectly suggests that enhanced Erk signaling may be superior to enhanced NF - κΒ activation in facilitating T cell activity against
tumor, especially because DKO mice did not exhibit improved
tumor control
relative to DGKζ − / − mice.